R&D

 

The blending of carefully selected internal development activities, complemented by highly focused associations with innovative development partners and medical specialists.

At BARD, our goal is to provide a constant supply of new, innovative medical technologies that improve clinical outcomes and help to control the costs of care.  Our products are responsive to the needs of healthcare practitioners and are sensitive to the issues of patient safety, comfort, and care.  We originate and develop products through the innovative thinking, skills, and capabilities of our Research and Development organization and through outside resources from which we identify, acquire, and develop new medical technologies.

Click here for information on the Idea Generation Process.
 

BARD leverages its capabilities in product development, and its demonstrated ability to commercialize products in a timely fashion to attract suitable partners from the academic, practitioner and industrial communities to ensure that products and product development opportunities from other organizations will properly supplement its internal development efforts.

 R&D Chart 3-26-14 

One of our most critical components of revenue growth strategy is our ability to identify, manufacture and market innovative, technology-based solutions to treat disease and disability.   BARD's significant increase in R&D investment in recent years- from $53 million in 2001 to $295 million in 2013 - is a measure of our commitment to innovation and evidence of our ability to execute growth strategy.

In recent years, our increased focus on R&D has yielded some significant results.  We have strengthened our infrastructure, creating an interactive R&D Council to share diverse experiences, and leverage ideas and best practices among our divisions. 

 


Who's Bard at a Glance
AboutBardRightImage